Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Healthcare CRO Services Market, by Service Type
1.4.2 Global Healthcare CRO Services Market, by End User
1.4.3 Global Healthcare CRO Services Market, by Therapeutic Area
1.4.4 Global Healthcare CRO Services Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Aug – 2020, Mar) Leading Players
Chapter 4. Global Healthcare CRO Services Market by Service Type
4.1 Global Clinical Research Services Market by Region
4.2 Global Early Phase Development Market by Region
4.3 Global Laboratory Services Market by Region
4.4 Global Consulting Services Market by Region
Chapter 5. Global Healthcare CRO Services Market by End User
5.1 Global Pharmaceutical Sector Market by Region
5.2 Global Medical Device Sector Market by Region
5.3 Global Academic Institutes Market by Region
Chapter 6. Global Healthcare CRO Services Market by Therapeutic Area
6.1 Global Oncology Market by Region
6.2 Global CNS Disorder Market by Region
6.3 Global Cardiovascular Disease Market by Region
6.4 Global Diabetes Market by Region
6.5 Global Metabolic Diseases Market by Region
6.6 Global Infectious Diseases Market by Region
6.7 Global Other therapeutic areas Market by Region
Chapter 7. Global Healthcare CRO Services Market by Region
7.1 North America Healthcare CRO Services Market
7.1.1 North America Healthcare CRO Services Market by Service Type
7.1.1.1 North America Clinical Research Services Market by Country
7.1.1.2 North America Early Phase Development Market by Country
7.1.1.3 North America Laboratory Services Market by Country
7.1.1.4 North America Consulting Services Market by Country
7.1.2 North America Healthcare CRO Services Market by End User
7.1.2.1 North America Pharmaceutical Sector Market by Country
7.1.2.2 North America Medical Device Sector Market by Country
7.1.2.3 North America Academic Institutes Market by Country
7.1.3 North America Healthcare CRO Services Market by Therapeutic Areas
7.1.3.1 North America Oncology Market by Country
7.1.3.2 North America CNS Disorder Market by Country
7.1.3.3 North America Cardiovascular Disease Market by Country
7.1.3.4 North America Diabetes Market by Country
7.1.3.5 North America Metabolic Diseases Market by Country
7.1.3.6 North America Infectious Diseases Market by Country
7.1.3.7 North America Other therapeutic areas Market by Country
7.1.4 North America Healthcare CRO Services Market by Country
7.1.4.1 US Healthcare CRO Services Market
7.1.4.1.1 US Healthcare CRO Services Market by Service Type
7.1.4.1.2 US Healthcare CRO Services Market by End User
7.1.4.1.3 US Healthcare CRO Services Market by Therapeutic Areas
7.1.4.2 Canada Healthcare CRO Services Market
7.1.4.2.1 Canada Healthcare CRO Services Market by Service Type
7.1.4.2.2 Canada Healthcare CRO Services Market by End User
7.1.4.2.3 Canada Healthcare CRO Services Market by Therapeutic Areas
7.1.4.3 Mexico Healthcare CRO Services Market
7.1.4.3.1 Mexico Healthcare CRO Services Market by Service Type
7.1.4.3.2 Mexico Healthcare CRO Services Market by End User
7.1.4.3.3 Mexico Healthcare CRO Services Market by Therapeutic Areas
7.1.4.4 Rest of North America Healthcare CRO Services Market
7.1.4.4.1 Rest of North America Healthcare CRO Services Market by Service Type
7.1.4.4.2 Rest of North America Healthcare CRO Services Market by End User
7.1.4.4.3 Rest of North America Healthcare CRO Services Market by End User
7.2 Europe Healthcare CRO Services Market
7.2.1 Europe Healthcare CRO Services Market by Service Type
7.2.1.1 Europe Clinical Research Services Market by Country
7.2.1.2 Europe Early Phase Development Market by Country
7.2.1.3 Europe Laboratory Services Market by Country
7.2.1.4 Europe Consulting Services Market by Country
7.2.2 Europe Healthcare CRO Services Market by End User
7.2.2.1 Europe Pharmaceutical Sector Market by Country
7.2.2.2 Europe Medical Device Sector Market by Country
7.2.2.3 Europe Academic Institutes Market by Country
7.2.3 Europe Healthcare CRO Services Market by Therapeutic Areas
7.2.3.1 Europe Oncology Market by Country
7.2.3.2 Europe CNS Disorder Market by Country
7.2.3.3 Europe Cardiovascular Disease Market by Country
7.2.3.4 Europe Diabetes Market by Country
7.2.3.5 Europe Metabolic Diseases Market by Country
7.2.3.6 Europe Infectious Diseases Market by Country
7.2.3.7 Europe Other therapeutic areas Market by Country
7.2.4 Europe Healthcare CRO Services Market by Country
7.2.4.1 Germany Healthcare CRO Services Market
7.2.4.1.1 Germany Healthcare CRO Services Market by Service Type
7.2.4.1.2 Germany Healthcare CRO Services Market by End User
7.2.4.1.3 Germany Healthcare CRO Services Market by Therapeutic Areas
7.2.4.2 UK Healthcare CRO Services Market
7.2.4.2.1 UK Healthcare CRO Services Market by Service Type
7.2.4.2.2 UK Healthcare CRO Services Market by End User
7.2.4.2.3 UK Healthcare CRO Services Market by Therapeutic Areas
7.2.4.3 France Healthcare CRO Services Market
7.2.4.3.1 France Healthcare CRO Services Market by Service Type
7.2.4.3.2 France Healthcare CRO Services Market by End User
7.2.4.3.3 France Healthcare CRO Services Market by Therapeutic Areas
7.2.4.4 Russia Healthcare CRO Services Market
7.2.4.4.1 Russia Healthcare CRO Services Market by Service Type
7.2.4.4.2 Russia Healthcare CRO Services Market by End User
7.2.4.4.3 Russia Healthcare CRO Services Market by Therapeutic Areas
7.2.4.5 Spain Healthcare CRO Services Market
7.2.4.5.1 Spain Healthcare CRO Services Market by Service Type
7.2.4.5.2 Spain Healthcare CRO Services Market by End User
7.2.4.5.3 Spain Healthcare CRO Services Market by Therapeutic Areas
7.2.4.6 Italy Healthcare CRO Services Market
7.2.4.6.1 Italy Healthcare CRO Services Market by Service Type
7.2.4.6.2 Italy Healthcare CRO Services Market by End User
7.2.4.6.3 Italy Healthcare CRO Services Market by Therapeutic Areas
7.2.4.7 Rest of Europe Healthcare CRO Services Market
7.2.4.7.1 Rest of Europe Healthcare CRO Services Market by Service Type
7.2.4.7.2 Rest of Europe Healthcare CRO Services Market by End User
7.2.4.7.3 Rest of Europe Healthcare CRO Services Market by Therapeutic Areas
7.3 Asia Pacific Healthcare CRO Services Market
7.3.1 Asia Pacific Healthcare CRO Services Market by Service Type
7.3.1.1 Asia Pacific Clinical Research Services Market by Country
7.3.1.2 Asia Pacific Early Phase Development Market by Country
7.3.1.3 Asia Pacific Laboratory Services Market by Country
7.3.1.4 Asia Pacific Consulting Services Market by Country
7.3.2 Asia Pacific Healthcare CRO Services Market by End User
7.3.2.1 Asia Pacific Pharmaceutical Sector Market by Country
7.3.2.2 Asia Pacific Medical Device Sector Market by Country
7.3.2.3 Asia Pacific Academic Institutes Market by Country
7.3.3 Asia Pacific Healthcare CRO Services Market by Therapeutic Areas
7.3.3.1 Asia Pacific Oncology Market by Country
7.3.3.2 Asia Pacific CNS Disorder Market by Country
7.3.3.3 Asia Pacific Cardiovascular Disease Market by Country
7.3.3.4 Asia Pacific Diabetes Market by Country
7.3.3.5 Asia Pacific Metabolic Diseases Market by Country
7.3.3.6 Asia Pacific Infectious Diseases Market by Country
7.3.3.7 Asia Pacific Other therapeutic areas Market by Country
7.3.4 Asia Pacific Healthcare CRO Services Market by Country
7.3.4.1 China Healthcare CRO Services Market
7.3.4.1.1 China Healthcare CRO Services Market by Service Type
7.3.4.1.2 China Healthcare CRO Services Market by End User
7.3.4.1.3 China Healthcare CRO Services Market by Therapeutic Areas
7.3.4.2 Japan Healthcare CRO Services Market
7.3.4.2.1 Japan Healthcare CRO Services Market by Service Type
7.3.4.2.2 Japan Healthcare CRO Services Market by End User
7.3.4.2.3 Japan Healthcare CRO Services Market by Therapeutic Areas
7.3.4.3 India Healthcare CRO Services Market
7.3.4.3.1 India Healthcare CRO Services Market by Service Type
7.3.4.3.2 India Healthcare CRO Services Market by End User
7.3.4.3.3 India Healthcare CRO Services Market by End User
7.3.4.4 South Korea Healthcare CRO Services Market
7.3.4.4.1 South Korea Healthcare CRO Services Market by Service Type
7.3.4.4.2 South Korea Healthcare CRO Services Market by End User
7.3.4.4.3 South Korea Healthcare CRO Services Market by End User
7.3.4.5 Singapore Healthcare CRO Services Market
7.3.4.5.1 Singapore Healthcare CRO Services Market by Service Type
7.3.4.5.2 Singapore Healthcare CRO Services Market by End User
7.3.4.5.3 Singapore Healthcare CRO Services Market by End User
7.3.4.6 Malaysia Healthcare CRO Services Market
7.3.4.6.1 Malaysia Healthcare CRO Services Market by Service Type
7.3.4.6.2 Malaysia Healthcare CRO Services Market by End User
7.3.4.6.3 Malaysia Healthcare CRO Services Market by End User
7.3.4.7 Rest of Asia Pacific Healthcare CRO Services Market
7.3.4.7.1 Rest of Asia Pacific Healthcare CRO Services Market by Service Type
7.3.4.7.2 Rest of Asia Pacific Healthcare CRO Services Market by End User
7.3.4.7.3 Rest of Asia Pacific Healthcare CRO Services Market by End User
7.4 LAMEA Healthcare CRO Services Market
7.4.1 LAMEA Healthcare CRO Services Market by Service Type
7.4.1.1 LAMEA Clinical Research Services Market by Country
7.4.1.2 LAMEA Early Phase Development Market by Country
7.4.1.3 LAMEA Laboratory Services Market by Country
7.4.1.4 LAMEA Consulting Services Market by Country
7.4.2 LAMEA Healthcare CRO Services Market by End User
7.4.2.1 LAMEA Pharmaceutical Sector Market by Country
7.4.2.2 LAMEA Medical Device Sector Market by Country
7.4.2.3 LAMEA Academic Institutes Market by Country
7.4.3 LAMEA Healthcare CRO Services Market by Therapeutic Areas
7.4.3.1 LAMEA Oncology Market by Country
7.4.3.2 LAMEA CNS Disorder Market by Country
7.4.3.3 LAMEA Cardiovascular Disease Market by Country
7.4.3.4 LAMEA Diabetes Market by Country
7.4.3.5 LAMEA Metabolic Diseases Market by Country
7.4.3.6 LAMEA Infectious Diseases Market by Country
7.4.3.7 LAMEA Other therapeutic areas Market by Country
7.4.4 LAMEA Healthcare CRO Services Market by Country
7.4.4.1 Brazil Healthcare CRO Services Market
7.4.4.1.1 Brazil Healthcare CRO Services Market by Service Type
7.4.4.1.2 Brazil Healthcare CRO Services Market by End User
7.4.4.1.3 Brazil Healthcare CRO Services Market by Therapeutic Area
7.4.4.2 Argentina Healthcare CRO Services Market
7.4.4.2.1 Argentina Healthcare CRO Services Market by Service Type
7.4.4.2.2 Argentina Healthcare CRO Services Market by End User
7.4.4.2.3 Argentina Healthcare CRO Services Market by Therapeutic Area
7.4.4.3 UAE Healthcare CRO Services Market
7.4.4.3.1 UAE Healthcare CRO Services Market by Service Type
7.4.4.3.2 UAE Healthcare CRO Services Market by End User
7.4.4.3.3 UAE Healthcare CRO Services Market by Therapeutic Area
7.4.4.4 Saudi Arabia Healthcare CRO Services Market
7.4.4.4.1 Saudi Arabia Healthcare CRO Services Market by Service Type
7.4.4.4.2 Saudi Arabia Healthcare CRO Services Market by End User
7.4.4.4.3 Saudi Arabia Healthcare CRO Services Market by Therapeutic Area
7.4.4.5 South Africa Healthcare CRO Services Market
7.4.4.5.1 South Africa Healthcare CRO Services Market by Service Type
7.4.4.5.2 South Africa Healthcare CRO Services Market by End User
7.4.4.5.3 South Africa Healthcare CRO Services Market by Therapeutic Area
7.4.4.6 Nigeria Healthcare CRO Services Market
7.4.4.6.1 Nigeria Healthcare CRO Services Market by Service Type
7.4.4.6.2 Nigeria Healthcare CRO Services Market by End User
7.4.4.6.3 Nigeria Healthcare CRO Services Market by Therapeutic Area
7.4.4.7 Rest of LAMEA Healthcare CRO Services Market
7.4.4.7.1 Rest of LAMEA Healthcare CRO Services Market by Service Type
7.4.4.7.2 Rest of LAMEA Healthcare CRO Services Market by End User
7.4.4.7.3 Rest of LAMEA Healthcare CRO Services Market by Therapeutic Area
Chapter 8. Company Profiles
8.1 IQVIA Holdings, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.2 Laboratory Corporation of America Holdings (Covance, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.1 Recent strategies and developments:
8.2.1.1 Product Launches and Product Expansions:
8.2.1.2 Acquisition and Mergers:
8.2.1.3 Geographical Expansions:
8.3 Pharmaceutical Product Development, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Geographical Expansions:
8.3.4.2 Acquisition and Mergers:
8.3.4.3 Partnerships, Collaborations, and Agreements:
8.4 Parexel International Corporation (Pamplona Capital Management)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Acquisition and Mergers:
8.4.2.2 Partnerships, Collaborations, and Agreements:
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.5.4.2 Partnerships, Collaborations, and Agreements:
8.6 ICON PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Product Launches and Product Expansions:
8.6.4.2 Acquisition and Mergers:
8.6.4.3 Partnerships, Collaborations, and Agreements:
8.7 Dassault Systemes SE (Medidata Solutions, Inc.)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Syneos Health, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Recent strategies and developments:
8.8.4.1 Partnerships, Collaborations, and Agreements:
8.9 Pharmaron Beijing Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.1 GVK Biosciences Private Limited
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 